Abstract
The initial stages of SARS-CoV-2 coronavirus attachment to human cells are mediated by non-covalent interactions of viral spike (S) protein receptor binding domains (S-RBD) with human ACE2 receptors (hACE2). Structural characterization techniques, such as X-ray crystallography (XRC) and cryoelectron microscopy (cryo-EM), previously identified SARS-CoV-2 spike protein conformations and their surface residues in contact with hACE2. However, recent quantum-biochemical calculations on the structurally related S-RBD of SARS-CoV-1 identified some contact-residue fragments as intrinsically attractive and others as repulsive. This indicates that not all surface residues are equally important for hACE2 attachment. Here, using similar quantum-biochemical methods, we report some four-residue fragments (i.e quartets) of the SARS-CoV-2 S-RBD as intrinsically attractive towards hACE2 and, therefore, directly promoting host–virus non-covalent binding. Other fragments are found to be repulsive although involved in intermolecular recognition. By evaluation of their respective intermolecular interaction energies we found two hACE2 fragments that include contact residues (ASP30, LYS31, HIS34) and (ASP38, TYR41, GLN42), respectively, behaving as important SARS-CoV-2 attractors. LYS353 also promotes viral binding via several mechanisms including dispersion van der Waals forces. Similarly, among others, three SARS-CoV-2 S-RBD fragments that include residues (GLN498, THR500, ASN501), (GLU484, PHE486, ASN487) and (LYS417), respectively, were identified as hACE2 attractors. In addition, key hACE2 quartets identified as weakly-repulsive towards the S-RBD of SARS-CoV-1 were found strongly attractive towards SARS-CoV-2 explaining, in part, the stronger binding affinity of hACE2 towards the latter coronavirus. These findings may guide the development of synthetic antibodies or identify potential viral epitopes.
Highlights
The initial stages of SARS-CoV-2 coronavirus attachment to human cells are mediated by noncovalent interactions of viral spike (S) protein receptor binding domains (S-RBD) with human ACE2 receptors
Computational methods can use the structural information provided by X-ray crystallography (XRC) or cryoelectron microscopy (cryo-EM) to fill gaps in molecular-level understanding of coronavirus binding to human ACE2 receptors (hACE2)
We found that hACE2 quartet AQ4 (GLU37-ASP38-TYR41-GLN42) is strongly attractive towards both viral S-RBDs with interaction energies of approximately − 55 and − 62 kcal/mol for SARS-CoV-17 and SARS-CoV-2 (Table 1), respectively
Summary
The initial stages of SARS-CoV-2 coronavirus attachment to human cells are mediated by noncovalent interactions of viral spike (S) protein receptor binding domains (S-RBD) with human ACE2 receptors (hACE2) Structural characterization techniques, such as X-ray crystallography (XRC) and cryoelectron microscopy (cryo-EM), previously identified SARS-CoV-2 spike protein conformations and their surface residues in contact with hACE2. The method combines density functional calculations with van der Waals dispersion contributions[22] to establish a relationship between the molecular structure of host-virus interface fragments and their corresponding, attractive or repulsive, interaction energies[7] We used this fragment-based approach with two recent XRC structures of the SARS-CoV-2 spike protein in complex with hACE214,15. These XRC structures are structurally similar at the host-virus interface and correspond to similar, thermodynamically-favorable, conformations
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.